title: Comment: Analysis of the influence of dabigatran on coagulation factors and inhibitors.
authors.affiliation: Davis Health System, University of California, Sacramento, CA, USA. rcgosselin@ucdavis.edu.
authors.forename: R C
authors.initials: RC
authors.lastname: Gosselin
authors.affiliation: Colorado Coagulation Laboratory Corporation of America® Holdings, Englewood, CO, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Adcock
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests / Q000592:standards*; D000069604:Dabigatran / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D000069604:Dabigatran